Forensic Laboratory Systems: A Global Overview

When a defence lawyer challenges a forensic result, the first questions are technical: was the method validated, were controls run, was the instrument calibrated? But close behind come organisational questions. Was the lab independent of the investigating agency? Was it accredited? Did it have a proficiency testing programme? Did it have an error-rate database? These questions are organisational, but their answers are scientific, and courts in multiple jurisdictions have started demanding answers to both sets.

Poorly organised lab systems produce predictable failure modes. Labs embedded in police departments are vulnerable to confirmation bias, where analysts drift toward results consistent with the investigation's hypothesis. Underfunded regional labs accumulate backlogs that degrade evidence: biological samples degrade, witness memories fade, and suspects remain in pretrial detention. Private labs without public oversight can cut corners on method validation to compete on price. None of these failures require individual misconduct; they emerge from the structure.

The United States does not have a single national forensic laboratory system. What it has is a patchwork: the FBI Laboratory at Quantico, Virginia; the Drug Enforcement Administration's labs; the Bureau of Alcohol, Tobacco, Firearms and Explosives laboratories; and then roughly 400 publicly operated state and local crime labs, plus an unknown number of private providers. Each major federal agency maintains its own forensic capacity, and each of the 50 states funds labs under different governance models, budgets, and accreditation regimes.

The FBI Laboratory, opened in 1932, handles a very specific slice of work: federal investigations, cases requested by other agencies, and highly specialised analyses not available elsewhere, such as hair microsopy comparison and certain explosives examinations. It is one of the few forensic labs in the world with an independent research arm that publishes in peer-reviewed journals. But it handles a tiny fraction of the total case volume. The vast majority of American forensic work flows through state and county crime labs with widely varying budgets, staffing, and quality systems.

The fragmentation creates real equity problems. A suspect in a well-funded county gets rapid DNA turnaround with an accredited lab and an internal quality review. A suspect in a low-budget jurisdiction may wait months in a backlog, in a lab that is not ISO 17025 accredited and has no external audit programme. The 2009 National Academy of Sciences report was blunt about this: it called the situation a national crisis.

The Forensic Science Service grew out of the Home Office Forensic Science Service, which had operated regional public laboratories since the 1930s. In 1991 the FSS was reorganised as a government agency on a trading-fund basis, meaning it had to recover its costs from the police forces that sent it work. By the 2000s it was competing against a growing private sector, including LGC Forensics and Orchid Cellmark, which had entered the market as DNA analysis became more standardised and commoditised.

The FSS accumulated losses as police forces, facing their own budget pressures, shifted routine DNA and drug work to cheaper private providers. The government, concluding it should not subsidise a competitor in a functioning market, announced closure in 2010 and completed it in 2012. Overnight, England and Wales moved from a model with one dominant public provider to a model with multiple competing private ones, coordinated loosely through police-force procurement and accredited by UKAS.

The UK model today is a competitive market supervised by the Forensic Science Regulator, a statutory post created in 2021 (the Forensic Science Regulator Act gave the role statutory powers after years of advisory-only status). The Regulator sets Codes of Practice and Conduct, monitors compliance, and can require remedial action. Providers must be UKAS-accredited to ISO 17025 for the analyses they offer. The model works reasonably for routine high-volume work; whether it will handle genuinely novel analytical challenges is a standing question.

Continental European countries have generally maintained publicly funded national forensic institutes. The Netherlands Forensic Institute (NFI), founded in 1945, operates under the Ministry of Justice and Security, carrying out complex casework for Dutch prosecutors and defence teams and publishing extensively in peer-reviewed journals. It runs an international advisory arm. Germany operates the Bundeskriminalamt (BKA) laboratory in Wiesbaden as the national police forensic centre, with 16 state-level criminal investigation offices each maintaining their own forensic capacity underneath it.

France provides a distinctive example because it runs two parallel national services: the Institut de Recherche Criminelle de la Gendarmerie Nationale (IRCGN), which serves the gendarmerie and handles complex technical casework, and the Institut National de Police Scientifique (INPS), which serves the national police with regional laboratories. Having two parallel national services is unusual, and reflects France's dual police structure rather than a deliberate forensic policy choice.

Australia sits between European and US models. Each state and territory funds its own forensic laboratory, and there is no single national forensic institute, but the Australian federal police maintain a national laboratory for federal matters. The Victorian Institute of Forensic Medicine (VIFM) and Forensic Science NSW are among the most research-active labs in the southern hemisphere. The European Network of Forensic Science Institutes provides a forum for national institutes to share methods and quality standards across the continent.

Proponents of privatisation argued that competition drives down cost, innovation, and turnaround time, all of which are genuinely useful goals in a science struggling with backlogs. These arguments are not wrong. UK police forces did see reduced costs for routine DNA and toxicology work after the FSS closed. Private labs did invest in automation that increased throughput.

• Independence: private labs answer to paying clients (usually police forces), which creates a similar pressure to police-embedded labs if procurement is not carefully managed. The key structural protection is that neither the prosecutor nor the investigator selects the analyst for individual cases.
• Research capacity: private labs tend not to invest in foundational research. The FSS's research department produced validated methods used globally. No private successor has replicated that investment.
• Knowledge preservation: when the FSS closed, institutional knowledge accumulated over decades dispersed across multiple employers. Some retired. Complex historical casework became harder to revisit.
• Novel crime types: a competitive market selects for profitable, high-volume analysis. Emerging challenges, new drug analogues, novel digital-physical intersections, low-volume specialisms, may fall into gaps if no individual provider sees them as commercially worthwhile.

Whether a lab is public or private, national or local, the baseline assurance mechanism is accreditation to ISO 17025 by a recognised accreditation body. The standard requires a lab to document its methods, demonstrate that each method is fit for its stated purpose, run quality controls, maintain equipment calibration records, manage and investigate errors, and participate in proficiency testing. An ISO 17025 certificate is not a guarantee of correctness in any individual case, but it does mean the lab has a system designed to catch and correct errors over time.

National accreditation bodies vary: UKAS in the UK, A2LA and ANAB in the United States, RvA in the Netherlands, DAkkS in Germany. All of these are signatories to the International Laboratory Accreditation Cooperation (ILAC) mutual recognition arrangement, which means their certificates are accepted internationally. This matters for cross-border casework and for international standards alignment.

Countries that have built functional forensic science systems share several characteristics. They separated forensic science from direct law-enforcement control early, either through independent agencies or through clear governance firewalls. They invested in foundational method validation before scaling capacity. They built quality systems, including proficiency testing and error investigation, before procurement pressure eroded them. And they maintained research connections, either inside national institutes or through university partnerships, so methods could evolve alongside crime and technology.

1. Establish governance independence
   The forensic body should report to the justice system, not the investigative police agency. Even a firewall within a ministry is better than direct operational embedding.
2. Mandate and fund accreditation
   ISO 17025 accreditation should be a legal requirement for court-admissible evidence, not a voluntary quality badge. Governments that treat it as optional create a race to the bottom on cost.
3. Build tiered referral pathways
   Routine work at regional or district labs, complex or novel analyses at a national centre with deeper specialist capacity. The hierarchy ensures coverage without requiring every lab to have every skill.
4. Fund research separately
   Method development cannot pay for itself in case fees. A ring-fenced research budget, or a mandated university partnership model, is what keeps the science current.